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ABSTRACT
MicroRNAs (miRNAs) are key biological regulators
and promising disease markers whose detection
technologies hold great potentials in advancing
fundamental research and medical diagnostics.
Currently, miRNAs in biological samples have to
be labeled before being applied to most high-
throughput assays. Although effective, these
labeling-based approaches are usually labor-
intensive, time-consuming and liable to bias.
Besides, the cross-hybridization of co-existing
miRNA precursors (pre-miRNAs) is not adequately
addressed in most assays that use total RNA as
input. Here, we present a hybridization-triggered
fluorescence strategy for label-free, microarray-
based high-throughput miRNA expression profiling.
The total RNA is directly applied to the microarray
with a short fluorophore-linked oligonucleotide
Universal Tag which can be selectively captured by
the target-bound probes via base-stacking effects.
This Stacking-Hybridized Universal Tag (SHUT)
assay has been successfully used to analyze as
little as 100ng total RNA from human tissues, and
found to be highly specific to homogenous
miRNAs. Superb discrimination toward single-base
mismatch at the 50 or 30 end has been demonstrated.
Importantly, the pre-miRNAs generated negligible
signals, validating the direct use of total RNA.
INTRODUCTION
The 1993 discovery of lin-4 in Caenorhabditis elegans is the
ﬁrst in a class of endogenous small regulatory RNAs
(typical length  22nt) later bearing the name
microRNA (miRNA) (1). Since then, the total number
of distinct mature miRNAs has grown to more than
17000 in over 140 species, according to miRBase release
16 (2). As negative post-transcriptional regulators of gene
expression (3,4), these tiny molecules play pivotal roles in
many fundamental aspects of life, such as plant and
animal development, tissue differentiation, metabolic
modulation and cell proliferation control (5,6). To appre-
ciate the profound impact that miRNA networks have on
our health, one may just consult the simple estimation that
at least one-third of all human genes are subject to
miRNA regulation (7,8). Indeed, mounting studies have
revealed miRNAs as signatures associated with various
human diseases (9–11). Recent ﬁndings that miRNAs
are present in both plasma and saliva in a remarkably
stable form brought the anticipated ‘miRNA disease
markers’ even closer (12,13). In the years to come, the
pursuits of further elucidating or exploiting miRNAs
will continue to intensify among researchers and
companies from diverse ﬁelds.
This bright future, however, would be unimaginable
without the aid of state-of-the-art technology to acquire
genome-wide high-quality miRNA expression data, espe-
cially when it comes to the intricate nature of miRNAs
like small size, wide range of melting temperature and
large number of highly homologous sequence variants
(14,15). At present, quantitative polymerase chain
reaction (qPCR), oligo microarray and deep sequencing
are three primary technical platforms for miRNA expres-
sion proﬁling, each with its own strengths and shortcom-
ings (15). Sequencing has the highest discerning power and
uncontested advantage of identifying unknown miRNAs;
qPCR covers a larger dynamic range and is regularly
deemed as the ‘gold standard’ for gene expression.
Nevertheless, the enzyme-based ligation and ampliﬁcation
steps involved in these two methods introduce inherent
biases. In addition, long runtime and complicated bio-
informatics for data interpretation are extra burdens of
sequencing, while the typical throughput of qPCR is
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Generally, sequencing is considered the best choice for
discovery of novel miRNAs and analysis of tiny vari-
ations, and qPCR the most reliable validation tool of
proﬁling results. Between them, multiple microarray
platforms serve as efﬁcient and economic workhorses
for vast high-throughput miRNA proﬁling tasks (16,17).
Advantages of microarray also include skip of ampliﬁca-
tion and modest runtime. Several studies aiming to cus-
tomize microarrays for improved miRNA proﬁling
performance have been reported in recent years (18–22).
However, microarrays are by no means acting perfectly. A
major concern is the drawbacks associated with the
labeling procedure (15,23), which is essential to current
miRNA microarrays. In a recent systematic survey of
mainstream commercial miRNA microarrays, all six
investigated platforms are label-based (24). Labeling pro-
cedures are usually laborious, expensive, some are not
suitable for certain type of miRNAs and, most import-
antly, they are prone to biases, artiﬁcial errors and respon-
sible for much of cross-platform variability (16). In fact,
current commercial microRNA microarray systems were
reported to have poor performances in terms of
inter-platform concordance (25). Although some of these
problems were partially solved in the RAKE assay devised
by Nelson et al. (20) via post-hybridization labeling, re-
maining difﬁculties accompany the usage of two different
enzymes could not be eradicated.
On the other hand, novel efforts have been continuously
made to develop alternative non-labeling methods for
direct miRNA detection in the past decade (26,27).
Proposed approaches include molecular beacon (28), elec-
trochemical device (29), enzyme-based colorimetric detec-
tion (30), surface plasmon resonance (SPR) (31),
surface-enhanced Raman spectroscopy (SERS) (32),
silicon nanowire (33), nanomechanics (34) and so on.
Apparently, the label-free approach has won much favor
among a wide array of researches aiming to provide in-
novative solutions for miRNA detection. Unfortunately,
even with the usually inadequately addressed speciﬁcity
issue put aside, most of these techniques came at the
price of poor multiplexity, or declined sensitivity, or
lack of robustness or dependence on less-accessible
sophisticated instruments, and eventually failed to raise
signiﬁcant challenges to established platforms when
entering the practical arena. Surprisingly, none of these
attempts sought the possibility of reconﬁguring the canon-
ical ﬂuorescent microarray, one of the most reliable and
widely used expression proﬁling technologies, to work in a
label-free manner.
Here, we report a ﬂuorescent microarray-based
label-free method that we termed Stacking-Hybridized
Universal Tag (SHUT) assay for simple, robust and
accurate high-throughput miRNA proﬁling. ‘Stacking hy-
bridization’ is referred to the additional stability
associated with DNA hybridization reactions wherein
two or more DNA oligonucleotides hybridize in a contigu-
ous tandem arrangement to a longer complementary
DNA single strand. Mirzabekov’s laboratory ﬁrst de-
veloped the stacking hybridization technology for DNA
sequencing on gel-based microarrays (35), and assessed
the stacking effect by measuring the increase of melting
temperature and free energy of the duplexes formed by
stacking hybridization (36). It has been demonstrated
capable of single-nucleotide polymorphism (SNP) detec-
tion (37).
Evolved from conventional ﬂuorescent microarray tech-
nology, the SHUT assay bears inherent gifts such as ex-
cellent multiplexity and high sensitivity, which are still the
quests of many other label-free approaches. Furthermore,
the SHUT assay allows direct use of total RNA extracted
from biological samples as input material, while most es-
tablished microarray methods may suggest otherwise.
MATERIALS AND METHODS
DNA and RNA sources
Probe DNA oligonucleotides complementary to publicly
available miRNA target sequences, Cy3-labeled universal
tag (UT) DNA oligonucleotides, PCR primers and RT
primers were synthesized and puriﬁed by Bioneer
(Shanghai) Co., Ltd (Korea). Synthetic RNA were
ordered from TaKaRa Biotechnology (Dalian) Co., Ltd
(Japan). Total RNA from six human tissues (brain, heart,
liver, placenta, skeletal muscle, and thymus) were
purchased from Ambion, Inc. (USA) and were used
without further fractionation or enrichment.
Microarray fabrication
C6 amine end-linked DNA oligonucleotide probes were
dissolved in spotting buffer [pH 9.0, 0.1M sodium carbon-
ate, 1.5M betaine, 20% dimethyl sulfoxide (DMSO)] to
prepare 20mM working solutions. Except the ‘targeting
probes’, three negative control probes were included to
estimate ﬂuorescence background and background
variance; and one (pos-RNA, in speciﬁcity and sensitivity
experiments) or three (Zip-5, Zip-13 and Zip-21 in tissue
miRNA proﬁling experiments) reference probe(s) were
used as exogenous controls. Probes were printed by a com-
mercial arrayer (PersonalArrayer 16, CapitalBio Co.,
China) to home-made aldehyde-activated glass slides at
24–26 C along with 50–55% humidity. Each slide may
contain up to eight individual microarrays. Each probe
was spotted in triplicate within an array. Typically, the
spot diameter was  150mm and the center-to-center
spacing was  350mm. The spotted slides were incubated
in a humid chamber overnight at room temperature, then
washed twice for 10min in 0.1% sodium dodecyl sulfate
(SDS), followed by thorough washing with ultrapure
water (Milli-Q Synthesis, Millipore, USA). The targeting
probe sequences used in speciﬁcity and sensitivity experi-
ments, and the sequences of control probes are listed in
Supplementary Table S3.
SHUT assay protocol
For miRNA proﬁling, 2.0mg, 0.5mg or 0.1mg total RNA
from each human tissue and 200nM (ﬁnal concentration)
Cy3-labeled reporter molecule (Universal Tag, or UT, see
Supplementary Table S3) were dissolved in hybridization
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DNA). The ﬁnal mixture volume was 45ml for each
sample, and was heated for 5min at 90 C and then
cooled on ice immediately before assay. Each 45ml
sample solution was dispensed to one well of the
SureHyb gasket slide (G2534-60014, Agilent
Technologies, Inc., USA), then an array slide was placed
down onto the SureHyb gasket slide with the array side
facing the target samples. The array/backing slide
sandwich was clamped into the SureHyb Hybridization
Chamber (Agilent G2534A), and hybridized at 42 C for
16h in a hybridization oven (Agilent 2545A) with a
constant rotation speed of 15 r.p.m. After hybridization,
slides were washed in 5  SSC and 0.1% SDS at 30 C for
6min, and then washed for 3min twice at room tempera-
ture in 0.2  SSC. The slides were immediately dried on a
slide centrifuge. For the sensitivity and speciﬁcity experi-
ments, the assay process was similar to that of the miRNA
proﬁling, while synthetic miRNAs at various assigned
concentrations were used as input sample instead of
tissue total RNAs.
Image scanning and data analysis
After hybridization and washing, slides were scanned
using a LuxScan 10K Microarray Scanner (CapitalBio
Co., China) at constant power and PMT gain settings
through a single-color channel (532nm wavelength).
Nonhybridized and artifact-associated spots were
removed by both visual inspection and software-guided
ﬂags. The raw pixel intensities were extracted using the
LuxScan 3.0 software (CapticalBio Co., China). Cy3
median pixel intensity values were background-
subtracted. Statistical analysis was performed using
OriginPro 8.1 software (OriginLab Co., USA) and R
statistical computing framework 2.12 (http://www.R-
project.org) (R Development Core Team 2010). Brieﬂy,
background-subtracted data were ﬁrst ﬁltered using their
signal/noise ratio (SNR) values with a threshold of 2 (for
an SNR lower than threshold the corresponding fea-
ture was ﬂagged ‘Not found’ by assigning its intensity
data to 1). Then, ‘within array’ normalization was per-
formed for different sub-arrays printed on the same
slide, using the geometric mean value of multiple
external (spiked-in) controls as the normalizing reference.
Next, sample data were corrected by subtraction of the
blank data (hybridization buffer containing only UT and
no miRNA) to remove probe-associated ﬂuorescence. For
replicates of the same biological sample on different
microarray slides, ‘between arrays’ normalization was per-
formed using the quantile normalization technique (38)
and the ‘normalizeBetweenArrays’ function in package
‘limma’ ver. 2.6.1 (39) of R 2.12. Finally, the arithmetic
average of log2-transformed normalized values of the
replicates was taken as the target miRNA’s expression
data.
Quantitative PCR
Please see Supplementary Data for a detailed description
of the qPCR procedure.
RESULTS
Microarray design strategy
The basic design of our SHUT probe (Figure 1) is a linear
assembly of three functional segments: (i) a 50 poly(A)
spacer sequence to extend the remaining part of the
probe away from the array’s solid surface; (ii) a 30
Trizol
extraction
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SHUT microarray
Washing
Scanning
Data image
Spacer
Catcher
Reporter{
{
{
Figure 1. A schematic diagram of the Stacking-Hybridized Universal Tag (SHUT) assay. The sample probe at the top of the ﬁgure illustrates the
generic structure of the DNA oligonucleotides used on the microarray. The nucleotides at the 50 end of the probe comprise an A10 spacer, followed
by the variable sequences targeting against speciﬁc miRNAs. The 30 end is complementary to the Universal Tag (UT) and shared by all capture
probes. A total RNA sample is extracted from cells by Trizol and hybridized to a spotted microarray with the Cy3-linked UT. After hybridization,
the slide is washed and scanned by a microarray scanner. The UT speciﬁcally bound to spots where probe-miRNA hybridization occurred.
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conjugated oligomer we termed Universal Tag (UT); and
(iii) in between them, a catcher sequence matching a
speciﬁc miRNA target. The catcher sequences are differ-
ent while the spacer and reporter are identical for all the
probes. According to this design, either the target miRNA
or the UT could hybridize to a speciﬁc part of the probe;
however, only the former (19–23bp) is thermodynamically
favorable under assay condition (42 C). As a result, in the
absence of target miRNA, a steady hybridization of the
short UT (melting temperature designed below 35 C) to
the probe hardly sustain, generating very faint back-
ground ﬂuorescence. Conversely, when target miRNA
binds to the catcher sequence, the hybridization of the
UT to the probe gains extra stability from the base
stacking effect between the two closely positioned end nu-
cleotides (one on UT and the other on the miRNA), suf-
ﬁcient to tether the UT to the probe (36). In this way, we
combined target capturing and ﬂuorescent signaling in a
single step, just like any conventional hybridization assay,
but without labeling the targets.
For the whole scheme to work, the starting point is to
ﬁnd a proper oligomer to serve as the Universal Tag. Too
short a UT, the duplex could be unlikely to form even if
the targets had hybridized to the probes to provide the
stacking sites; too long a UT, it could maintain a stable
hybridization to the probe without the target miRNAs.
This was accounted for experimentally to ﬁnd an
optimal UT length to be used throughout this study. We
tested three probe/UT hybrid lengths using a 50
dye-labeled 9-mer DNA oligo (designated Tag-9, see
Supplementary Table S3 for its sequence) and three
SHUT probes targeting miR-195. The probes (designated
P7_miR-195, P8_miR-195 and P9_miR-195, respectively,
see Supplementary Table S3 for the sequences) have iden-
tical sequences except at the 30 end they are 7bp, 8bp and
9bp complementary to Tag-9, respectively (Figure 2A).
miR-195 (200 pM) were used as target. As expected, the
target signal intensity (Figure 2B) is positively correlated
to the probe/UT hybrid length. The target signal of the
9bp hybrids is slightly higher than that of the 8bp hybrids
and both signiﬁcantly exceeds that of the 7bp hybrids; yet
the 9-bp hybrids generates high blank signal while signals
of 7bp and 8bp hybrids are negligible. Based on the above
observations, we designed an 8-mer DNA oligo (one base
shorter than Tag-9 at the 50 end) as the Universal Tag (see
Supplementary Table S3 for its sequence).
Speciﬁcity
A distinctive nature of miRNAs concerning the detection
speciﬁcity is the presence of highly homologous family
members. Many family members differ in only 1–3 nt.
This sequence similarity may pose extra difﬁculties when
it is necessary to distinguish speciﬁc miRNAs from their
family members. Therefore, recognizing such subtle differ-
ences is critical for any successful miRNA proﬁling tech-
nology. To examine the speciﬁcity of the SHUT assay,
200pM synthetic human let-7a, let-7b, let-7d and let-7f
miRNA target was applied to a microarray containing
let-7a, let-7b, let-7d and let-7f probes, respectively. Most
cross-hybridizations observed were under 25% except for
probe let-7f and miRNA let-7a (the difference between
let-7a and let-7f is a single-base mismatch in the middle
of the sequence), which is well acceptable for the purpose
of discrimination (Figure 3A). The few higher cross-
hybridization instances (mostly single-nucleotide A/G or
C/T substitutions) could be further reduced via probe
design optimization by adoption of proposed single-base
mismatch discrimination microarray strategies such as
ProDeG (40).
In light of previous report by Mirzabekov’s group that
either a single-base mismatch, overlap or single gap in
stacking site would effectively hinder the stacking inter-
action(36), we expect the SHUT assay to possess extraor-
dinary speciﬁcity toward single-base terminal variations.
This was ﬁrst demonstrated by detecting two miRNAs
(miR-106a and miR-17) whose only difference is the ﬁrst
nucleotide at the 50 end position. Each of the miRNAs was
individually applied to an array containing both of the
probes, and comparison was made between the signals
generated on the same probes (Figure 3B). In both
cases, a sharp signal drop (higher than 90%) was
A
B
Figure 2. Optimization of Universal Tag (UT) length. (A) Three
SHUT probes targeting miR-195 with different hybridization length
to a 9-mer ﬂuorescent DNA oligo (Tag-9) were designed (the
base-pairing number of the probe/UT complementary duplex was
annotated near the probe). The base-stacking site was indicated by a
blue box. Note that the remaining part of the probes and miR-195 were
omitted. (B) Detection of 200pM miR-195. Tag-9 concentration:
200nM. Buffers containing 200nM Tag-9 without miR-195 served as
blank controls. Error bars: SD (n=3).
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30-immobilized probes and 30-dyed universal tag
(designated UT0, whose sequence is the reverse of the
original 50-dyed UT) to detect two miRNAs (miR-133a
and miR-133b) only that differs at their 30 end position,
and obtained similar results (Figure 3C).
Another potential factor affecting the miRNA assay
speciﬁcity is the co-existence of pri-miRNAs and
pre-miRNAs in vivo. These RNA species contain se-
quences identical to mature miRNAs, yet only the
mature ones are the active players that are assembled
into RNA-induced silencing complexes (RISCs) (41).
Consequently, unless the cross-hybridization of pri- and
pre-miRNAs prevented or effectively suppressed, the data
obtained from an miRNA assay has to be considered
prone to false-positive errors (14). A common practice is
to reduce the complexity of biological samples through
fractionation to isolate the low-molecular-weight
miRNAs from the more abundant high-molecular-weight
species before miRNA proﬁling (19,42,43). However, our
SHUT method can process total RNA directly extracted
from biological samples. This is demonstrated by subject-
ing a synthesized precursor human miRNA, pre-miR-31
(44), along with either of the two mature miRNAs
(miR-31 and miR-31*) derived from it to the SHUT
assay. The result showed that the precursor’s signal is
<5% of that of the mature miRNA in both cases
(Figure 3D).
Sensitivity and dynamic range
miRNAs represent only a small fraction ( 0.01%) of the
mass of a total RNA sample (43), yet its typical expression
level spans over four orders of magnitude (45). Hence, sen-
sitivity and linear dynamic range are critical determinants
when assessing a miRNA proﬁling method. To measure
the dynamic range and limit of detection (LoD) of the
SHUT assay, we conducted the hybridization using an
equimolar mixture of two synthetic miRNAs (let-7b and
miR-195). The concentration series varied from 200pM
down to 20fM. A short single-strand RNA (pos-RNA)
AB
CD
Figure 3. Speciﬁcity of the SHUT assay. All error bars are standard deviation of three replicates (n=3). (A) Discrimination of let-7 family members.
Signals were reported as the relative percentages of the intended target of each probe (taken as 100%). Positions that let-7b, let-7d and let-7f have
different bases to let-7a are highlighted. (B) Discrimination of miRNAs with single-base difference at the 50 end. Hybridization schemes drawn near
each column show typical reaction results of corresponding probe/miRNA/UT combination. Probes are depicted in the same color as its target. UT
(yellow) and UT0 (magenta) stands for 50 and 30 dye-linked universal tag, respectively. All hybridization duplexes are drawn according to the actual
base-pairing numbers. (C) Discrimination of miRNAs with single-base difference at the 30 end. (D) Pre-/mature miRNA discrimination. The stem–
loop structure shown in the center is pre-miR-31, the common precursor of two mature human miRNAs: miR-31 (orange) and miR-31* (blue).
Dashed line in pre-miR-31 stands for nucleotides not included in any of the two mature miRNA sequences (solid line). All hybridization duplexes are
drawn according to the actual base-pairing numbers. Note that under hybridization condition, the precursor is in an equilibrium of stem–loop/free
conformation, which is indicated by the double-direction arrows.
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external control. Figure 4 shows that as low as 20fM (cor-
responding to 0.9amol) target miRNA can be detected.
The coefﬁcients of determination (CoD R
2=0.968 for
let-7b and 0.928 for miR-195) indicate that the miRNA
analysis by SHUT assay can be made with a high degree of
conﬁdence across the measured concentration range.
High-throughput miRNA proﬁling using total RNA
from human tissues
The SHUT assay’s applicability for real biological samples
was tested by obtaining the expression proﬁles of a cohort
of 121 miRNAs in total RNA extracted from six human
tissues (Figure 5). For each tissue, 2.0mg total RNA was
used per assay. As the heat map shows, the measured ex-
pression level for some individual miRNAs are stable
across different tissues, while for many others it varies in
a wide range; consequently, the collective expression of the
cohort among different tissues is highly differentiated.
As a preliminary quality assessment for the proﬁling
data, two basic features were examined: (i) Repeatability.
The proﬁling experiments were performed on four repli-
cate microarray slides. Statistical tests showed all data
were not signiﬁcantly drawn from a normally distributed
population at  =0.05 level. For each tissue, the mean
expression level of all 121 miRNAs from the four micro-
arrays showed no signiﬁcant differences at  =0.01 level
(ANOVA test) to each other, indicating a good repeatabil-
ity. (ii) Quantiﬁcation capability. The result showed that
the signal produced by three spiked-in external control
miRNAs well maintained their original concentration
ratios (linearity of log signals of the three miRNAs:
R
2>0.97), indicates a good quantiﬁcation capability.
Further validation of the SHUT assay data was carried
by comparison of the expression levels of 12 miRNAs
(randomly picked from the 121-plex cohort) among the
0
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Figure 5. Heat map of expression proﬁle of 121 miRNAs in six human
tissues. Color represents log2-transformed expression data. The names
of the miRNAs are in accordance with miRBase Release 16. Three
non-human miRNAs (Zip-21, Zip-5 and Zip-13) were spiked-in as
external control to serve data normalization. The color key indicates
the signal intensities based on their log2 values. Error bars: SD (n=4).
Figure 4. Sensitivity and dynamic range of SHUT assay. Target
miRNAs were assayed at concentrations 20fM, 200fM, 2pM, 20pM
and 200pM, respectively. An external control RNA (pos-RNA) were
spiked in at a ﬁxed concentration of 2pM. Error bars: SD (n=3). The
obtained miRNA concentration-signal data were ﬁtted using a power
function model and the corresponding COD (correlation of determin-
ation) R
2 were indicated by arrows.
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data from these two sources highly agreed with each other.
Finally, the lowest sample requirement of the SHUT
assay was probed. Twenty miRNAs were assayed from
2.0, 0.5 and 0.1mg total RNA of brain tissue (Figure 7).
As we expected, the detected signal level for each individ-
ual miRNA fell as the input amount decreased from 2.0 to
0.5mg, and dropped further while only 100ng total RNA
was used. Nonetheless, the data also suggested that most
miRNAs are still detectable by the SHUT microarray
assay even when the sample input is extremely low. In
addition, more importantly, the proﬁling results as a
whole are consistent for the three different total RNA
inputs.
DISCUSSION
As a contradiction to common practice that miRNA
samples must be labeled before assay, the SHUT
strategy distinguishes itself from conventional methods
in that it denies the necessity of labeling procedures. In
particular, this strategy is realized in ﬂuorescent micro-
array format, which is long desired since it may grant
label-free approaches the power of high-throughput
along with high sensitivity/dynamic range performance.
Another ﬂuorescent label-free strategy is molecular
beacon, which emits ﬂuorescence upon hybridization of
an unlabeled target nucleic acid by separation of the
intramolecular-neighbored quencher–ﬂuorophore pair.
Figure 6. Quantitative real-time PCR (qRT-PCR) veriﬁcation of SHUT microarray proﬁling results. Twelve out of the 121 miRNAs that went the
high-throughput proﬁling assay were randomly picked for comparison. Relative expression using either qRT-PCR (azure) or SHUT assay (magenta)
were individually plotted for each of these miRNAs, and each miRNA’s expression levels in each tissue are reported as the fraction of the expression
level in the tissue in which that miRNA is most abundant. Error bars: SD (n=3 for qPCR and n=4 for SHUT assay).
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microarrays would require extra modiﬁcation of the
microarray probes with a ﬂuorophore and its pairing
quencher, which may dramatically increase the cost for
high-throughput detection. Not only that, the hairpin
structure of the molecular beacon immobilized on glass
surface are susceptible to denaturation, which eventually
leads to spontaneous departure of the quencher from
the ﬂuorophore, generating high background noise (46).
As a result, molecular beacon is well accepted for
solution-phase detection of nucleic acids, thus excluded
from multiplex tasks (27). In contrast, the solid-phase
SHUT assay is ideal for high-throughput proﬁling. It
needs no additional modiﬁcations of the microarray
probes, and efﬁciently suppresses the background signals
by elevating hybridization temperature to 7.6 C higher
than the Tm of UT to prevent it from attaching to the
free probes.
The SHUT assay is sensitive to both central and
terminal differences of miRNAs. Several enzyme-based
labeling methods have been reported to be sensitive to 30
end mismatches (20), but they are unable to detect 50 end
mismatches due to the 30 activity of the enzymes. Besides,
for miRNAs with natural modiﬁcations at 30 ends such as
plant miRNAs (47), enzymatic labeling would be prob-
lematic. Chemical labeling methods are insensitive to the
30 end modiﬁcations, but are suspicious of introducing
bias by selectively labeling certain nucleotides with
higher efﬁciency than others (23). Being both enzyme-
and label-free, the SHUT assay is immune to these draw-
backs. Its 50 and 30 end single-mismatch speciﬁcity has
been well demonstrated in this study. To the best of our
knowledge, there is no other array-based miRNA detec-
tion approach that can discriminate both 50 and 30 end
single-nucleotide alteration. Because of this unique advan-
tage, the SHUT assay could also serve as a valuable tool
when miRNA end-sequence variations become a major
concern of investigation (48,49). By expanding probe
coverage, the resolution of SHUT assay could be easily
tailored to offer more detailed information, such as the
expression of miRNA isoforms (isomiRs). Currently,
such in-depth assay works are predominately accom-
plished using sequencing-based approaches (50,51).
The interference caused by precursors is often
underestimated, if not overlooked, in most miRNA
assay techniques. For assays rely solely on the conform-
ational difference (linear versus hairpin) to tell mature
miRNAs from their precursors, it is crucial to sustain
the stability of the precursor’s stem–loop under assay con-
ditions. However, we have experimentally observed that at
42 C miRNA precursors could produce substantial
false-positive signal due to its unfolding and subsequent
competitive hybridization to the probes (Supplementary
Figure S1, right). Many other assays may suffer from
this phenomenon since by their working scheme hybrid-
ization means signaling. Yet, this is not the case for our
SHUT assay. By simply choosing the other end of target
miRNA as the stacking site (Supplementary Figure S1,
left) we can perfectly eliminate precursor’s interference
without impairing the ability to report mature miRNAs.
This is a unique beneﬁt of utilizing the base-stacking
mechanism for signal transduction. Brieﬂy, if additional
nucleotides present at the stacking site (as in the case
that pre-miR-31 hybridizes to the miR-31 probe,
Supplementary Figure S1, left), the stacking-induced
hybridization enhancing effect will diminish as the
base-stacking interaction seriously disrupted. In fact, just
one extra nucleotide at the miRNA’s ‘stacking end’ would
be sufﬁcient to cause a striking 10-fold decrease of signal
(see Supplementary Data and Supplementary Figure S2).
The sensitivity of many established miRNA assay
protocols might be impaired by factors such as sample
loss and inefﬁcient reaction, since one individual or a com-
bination of the following procedures is used in those
Figure 7. SHUT assay results of 20 miRNAs using different amount (2.0, 0.5, 0.1mg) of total RNA from human brain tissue as input samples.
Error bars: SD (n=3).
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and (iii) sample puriﬁcation. In the SHUT assay, sample
loss is avoid to a maximum extent by allowing direct use
of total RNA without any further manipulations. On the
other hand, the excessive concentration of the ﬂuorescent
UT used in the hybridization buffer helps to maintain a
high signal-transduction ratio for the target-hybridized
probes. Taken together, the above factors ensure a high
sensitivity performance of the assay.
The complexity of real biological samples may seriously
undermine a molecular assay’s quantitative precision.
Therefore, data validation is our main focus on the
121-plex miRNA proﬁling from different human tissues.
By matching the SHUT proﬁling data against that from
qPCR, we found that these two results correlated well with
each other, indicating a reliable performance of the SHUT
method under real application conditions. Further experi-
mental inquiry of the lower limit of sample requirement
suggests that (I) good data reproducibility as the total
RNA input amount decreased to a minimal level and
(ii) relatively high sensitivity in the context of using
limited raw sample without miRNA enrichment.
For molecular biology assays, any improvement on
reagent consumption and operational convenience could
be translated to economical efﬁciency. In SHUT assay, the
removal of labeling (fractionation/puriﬁcation as well)
procedure signiﬁcantly reduces the consumption of expen-
sive chemicals and bench works required in conventional
methods. In addition, simpliﬁcation of handling protocol
also helps to minimize potential experimental failures
caused by human errors.
In summary, we have designed a hybridization-triggered
ﬂuorescence strategy for label-free high-throughput
miRNA expression proﬁling, which is superior to most
existing chemical and enzymatic labeling methods in the
following aspects: (i) ﬂuorescent signaling without the aid
of enzymes; (ii) sharp speciﬁcity toward end sequence vari-
ations and mature/precursor miRNAs; (iii) excellent sen-
sitivity with a linear dynamic range over four orders of
magnitude; and (iv) substantial reduction of expenses on
reagents, labor and time. Furthermore, the principle could
be ﬂexibly adapted to many existing assay formats (PCR,
suspension arrays, etc.). From a methodological perspec-
tive, the base-stacking approach described here opens up
new opportunities to implement hybridization-triggered
ﬂuorescence strategy on solid-phase detection platforms,
whereas similar strategies based on molecular beacons are
almost exclusively used in solution-phase applications.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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